ATAD3A and head and neck squamous cell carcinoma: These results, therefore, indicate an as yet undescribed functional relevance of ATAD3A in HNSCC and provide a molecular basis for targeting ATAD3A to control HNSCC development, which may interest a range of cancer scientists and clinicians who seek to assess the feasibility of manipulating mitochondrial signaling for therapeutic purposes.